Literatur
-
1
Douketis J D, Johnson J A, Turpie A G.
Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Arch Intern Med.
2004;
164
1319-1326
-
2
Freeman W D, Brott T G, Barrett K M, Castillo P R, Deen H G, Czervionke L F, Meschia J F.
Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage.
Mayo Clin Proc.
2004;
79
1495-1500
-
3
Harder S, Klinkhardt U, Alvarez J M.
Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations.
Clin Pharmacokinet.
2004;
43
963-981
-
4
Heit J A.
Perioperative management of the chronically anticoagulated patient.
J Thromb Thrombolysis.
2001;
12
81-87
-
5
Holzheimer R G.
Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Eur J Med Res.
2004;
9
225-239
-
6
Jafri S M, Metha T P.
Periprocedural management of anticoagulation in patients on extended warfarin therapy.
Semin Thromb Hemost.
2004;
30
657-6
-
7
Douketis J, Kahn R S, Solymoss S, Wells P S.
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
J. Circulation.
2004;
110(12)
1658-1663
-
8
Makris M.
Optimisation of the prothrombin complex concentrate dose for warfarin reversal.
Thrombosis Research.
2005;
115
451-453
-
9
Merritt J C, Bhatt D L.
The efficacy and safety of perioperative antiplatelet therapy.
J Thromb Thrombolysis.
2004;
17
21-27
-
10
Mosler P, Mergener K, Denzer U, Kiesslich R, Galle P R, Kanzler S.
Current Practice in Managing Patients on Antikoagulants and/or Antiplatelet Agents around the Time of Gastrointestinal Endoskopy - A Nation-wide Survey in Germany.
Z Gastroenterol.
2004;
42
1289-1293
-
11
Ong A T, Serruys P W.
Drug-eluting stents: current issues.
Tex Heart Inst J.
2005;
32
372-377
-
12
Otley C C.
Continuation of medically necessary aspirin and warfarin during cutaneous surgery.
Mayo Clin Proc.
2003;
78
1392-1396
-
13
Pass S E, Simpson R W.
Discontinuation and reinstitution of medications during the perioperative period.
Am J Health Syst Pharm.
2004;
61
899-912
-
14
Voss R, Grebe M.
Perioperative/peri-interventionelle Antikoagulation.
Dtsch med Wochenschr.
2005;
130
2209-2212
-
15
Weitz J I, Bates S M.
New anticoagulants.
J Thromb Haemost.
2005;
3
1843-1853
Prof. Dr. Hanno Riess
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie
Augustenburger Platz 1
13353 Berlin
Telefon: 030/450553112
Fax: 030/450553901
eMail: hanno.riess@charite.de
